JP2021503008A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021503008A5 JP2021503008A5 JP2020544558A JP2020544558A JP2021503008A5 JP 2021503008 A5 JP2021503008 A5 JP 2021503008A5 JP 2020544558 A JP2020544558 A JP 2020544558A JP 2020544558 A JP2020544558 A JP 2020544558A JP 2021503008 A5 JP2021503008 A5 JP 2021503008A5
- Authority
- JP
- Japan
- Prior art keywords
- hematopoietic stem
- patient
- optionally substituted
- cells
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 Cc1c(CI*)c2nc(*)c(*)[n]2c(*)c1* Chemical compound Cc1c(CI*)c2nc(*)c(*)[n]2c(*)c1* 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762579776P | 2017-10-31 | 2017-10-31 | |
| US62/579,776 | 2017-10-31 | ||
| US201762596661P | 2017-12-08 | 2017-12-08 | |
| US62/596,661 | 2017-12-08 | ||
| PCT/US2018/058562 WO2019089833A1 (en) | 2017-10-31 | 2018-10-31 | Compositions and methods for hematopoietic stem and progenitor cell transplant therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021503008A JP2021503008A (ja) | 2021-02-04 |
| JP2021503008A5 true JP2021503008A5 (https=) | 2021-12-09 |
Family
ID=64650470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544558A Pending JP2021503008A (ja) | 2017-10-31 | 2018-10-31 | 造血幹細胞および前駆細胞移植療法のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190343885A1 (https=) |
| EP (1) | EP3703715A1 (https=) |
| JP (1) | JP2021503008A (https=) |
| CN (1) | CN111683669A (https=) |
| AU (1) | AU2018358054A1 (https=) |
| CA (1) | CA3079404A1 (https=) |
| WO (1) | WO2019089833A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX392743B (es) | 2017-04-12 | 2025-03-12 | Magenta Therapeutics Inc | Antagonistas del receptor de hidrocarburo de arilo y sus usos. |
| EP3735412B1 (en) * | 2018-01-03 | 2024-02-21 | EdiGene Biotechnology, Inc. | Compositions and methods for the expansion of hematopoietic stem and progenitor cells and treatment of inherited metabolic disorders |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5233044A (en) | 1989-06-08 | 1993-08-03 | Millipore Corporation | Active esters for solid phase peptide synthesis |
| US5021409A (en) | 1989-12-21 | 1991-06-04 | Johnson Matthey Plc | Antiviral cyclic polyamines |
| US5512421A (en) | 1991-02-19 | 1996-04-30 | The Regents Of The University Of California | Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| GB9126677D0 (en) | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| MD1367C2 (ro) | 1992-11-13 | 2000-11-30 | Idec Pharmaceuticals Corporation | Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom. |
| US6447766B1 (en) | 1993-06-08 | 2002-09-10 | Smithkline Beecham Corporation | Method of mobilizing hematopoietic stem cells |
| DE69433301T2 (de) | 1993-06-08 | 2004-09-09 | Smithkline Beecham Corp. | Methoden zur erhöhung der biologischen aktivität von chemokinen |
| GB9400411D0 (en) | 1994-01-11 | 1994-03-09 | Johnson Matthey Plc | Improvements in chemical compounds |
| US5547892A (en) | 1995-04-27 | 1996-08-20 | Taiwan Semiconductor Manufacturing Company | Process for forming stacked contacts and metal contacts on static random access memory having thin film transistors |
| US6506770B1 (en) | 1996-06-06 | 2003-01-14 | Anormed, Inc. | Antiviral compounds |
| US5801030A (en) | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
| HU226994B1 (en) | 1997-02-11 | 2010-04-28 | Mallinckrodt | Reactor and method for solid phase peptide synthesis |
| EP1068357B2 (en) | 1998-03-30 | 2014-12-10 | NorthWest Biotherapeutics, Inc. | Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| BR0010655A (pt) | 1999-03-24 | 2002-02-13 | Anormed Inc | Compostos heterocìclicos para ligação ao receptor de quimiocina |
| DE60042030D1 (de) | 1999-12-17 | 2009-05-28 | Genzyme Corp | Chemokinrezeptor-bindende heterocyclische verbindungen |
| CA2407651C (en) | 2000-04-27 | 2013-07-02 | Max-Delbruck-Centrum Fur Molekulare Medizin | Sleeping beauty, a transposon vector with a broad host range for the genetic transformation in vertebrates |
| DE60103052T2 (de) | 2000-05-09 | 2005-03-03 | The University Of British Columbia, Vancouver | Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten |
| CA2412436C (en) | 2000-06-05 | 2013-05-21 | The Trustees Of Columbia University In The City Of New York | Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| CA2456977C (en) | 2001-08-16 | 2011-06-07 | The Trustees Of The University Of Pennsylvania | Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| US20030199464A1 (en) | 2002-04-23 | 2003-10-23 | Silviu Itescu | Regeneration of endogenous myocardial tissue by induction of neovascularization |
| US7683036B2 (en) | 2003-07-31 | 2010-03-23 | Regulus Therapeutics Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
| JP2008509928A (ja) | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆／幹細胞を動員するためのケモカインの組み合わせ |
| CA2891996A1 (en) | 2005-10-18 | 2007-04-26 | Duke University | Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
| US8383095B2 (en) * | 2006-02-14 | 2013-02-26 | Cellerant Therapeutics, Inc. | Methods and compositions for enhancing engraftment of hematopoietic stem cells |
| KR20090021217A (ko) | 2006-06-14 | 2009-02-27 | 추가이 세이야쿠 가부시키가이샤 | 조혈 줄기세포 증가 촉진제 |
| EP1995316A1 (de) | 2007-05-25 | 2008-11-26 | Qiagen GmbH | Verfahren zur schonenden Zellaufreinigung, Zellgewinnung und Transfektion von Zellen |
| EP2009095A1 (en) | 2007-06-28 | 2008-12-31 | Innovalor AG | Method of generating glucose-responsive cells |
| EP2215223B1 (en) | 2007-10-31 | 2013-05-01 | Precision Biosciences, Inc. | Rationally-designed single-chain meganucleases with non-palindromic recognition sequences |
| PE20100362A1 (es) | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
| WO2010085699A2 (en) | 2009-01-23 | 2010-07-29 | The Johns Hopkins University | Mammalian piggybac transposon and methods of use |
| EP2270025A1 (en) | 2009-06-29 | 2011-01-05 | Centre National pour la Recherche Scientifique (CNRS) | Solid phase peptide synthesis of peptide alcohols |
| US9388212B2 (en) | 2013-02-21 | 2016-07-12 | Chemical & Biopharmaceutical Laboratories Of Patras S.A. | Solid phase peptide synthesis via side chain attachment |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| JP2016516672A (ja) * | 2013-02-28 | 2016-06-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 幹細胞を動員するための方法および組成物 |
| US9169287B2 (en) | 2013-03-15 | 2015-10-27 | Massachusetts Institute Of Technology | Solid phase peptide synthesis processes and associated systems |
| HK1249534A1 (zh) * | 2015-04-06 | 2018-11-02 | 哈佛大学校长及研究员协会 | 用於非清髓性预处理的组合物和方法 |
-
2018
- 2018-10-31 WO PCT/US2018/058562 patent/WO2019089833A1/en not_active Ceased
- 2018-10-31 EP EP18815378.7A patent/EP3703715A1/en not_active Withdrawn
- 2018-10-31 JP JP2020544558A patent/JP2021503008A/ja active Pending
- 2018-10-31 CA CA3079404A patent/CA3079404A1/en active Pending
- 2018-10-31 US US16/177,254 patent/US20190343885A1/en not_active Abandoned
- 2018-10-31 AU AU2018358054A patent/AU2018358054A1/en not_active Abandoned
- 2018-10-31 CN CN201880085039.4A patent/CN111683669A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502824A5 (https=) | ||
| Jurewicz et al. | Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes | |
| JP2021505172A5 (https=) | ||
| Lu et al. | Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia | |
| Terrell et al. | Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice | |
| Taylor et al. | Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD) | |
| Chhabra et al. | The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation | |
| Shenoy et al. | Unrelated donor transplantation in children with thalassemia using reduced-intensity conditioning: the URTH trial | |
| Bacigalupo et al. | Haploidentical donor transplants for severe aplastic anemia | |
| Taylor et al. | Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions | |
| Koreth et al. | Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results | |
| JP2018502117A5 (https=) | ||
| US20160243168A1 (en) | Adoptive cell transfer methods | |
| US20220168393A1 (en) | Il-12 compositions and methods of use in hematopoietic recovery | |
| JP2021503008A5 (https=) | ||
| Picardi et al. | Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma | |
| Jaiswal et al. | CTLA4Ig in an extended schedule along with sirolimus improves outcome with a distinct pattern of immune reconstitution following post-transplantation cyclophosphamide-based haploidentical transplantation for hemoglobinopathies | |
| Sodani et al. | T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients | |
| TW202309077A (zh) | 用於治療實性瘤的靶向ｃｄ７０的基因工程化免疫細胞 | |
| Gong et al. | Alternative transplantation with post-transplantation cyclophosphamide in aplastic anemia: a retrospective report from the BMF-WG of Hunan Province, China | |
| Foà et al. | Induction and persistence of complete remission in a resistant acute myeloid leukemia patient after treatment with recombinant interleukin-2 | |
| Hara et al. | High doses of gamma globulin and methylprednisolone therapy for idiopathic thrombocytopenic purpura in children | |
| Lee et al. | Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections | |
| Yim et al. | Successful recovery of poor graft function by administration of romiplostim in a multiple myeloma case with poor graft function following autologous stem cell transplantation | |
| Vrecenak et al. | Simple approach to increase donor hematopoietic stem cell dose and improve engraftment in the murine model of allogeneic in utero hematopoietic cell transplantation |